GMC-6139

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameGMC-6139
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsSerotonin 2c (5-HT2c) receptor antagonistsDopamine D1 receptor antagonists +[4] 
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptorDopamine D2 receptor +[4] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of GothenburgH. Lundbeck A/SMerck KGaA, Darmstadt, Germany +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Groningen, The NetherlandsH. Lundbeck A/SMerck KGaA, Darmstadt, Germany +[4] 
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A